Posted in: information

Why is clinical mass spectrometry the next”gene sequencing”?

With the development of precision medicine and the breakthrough in multi omics research, clinical mass spectrometry has ushered in its opportunity. From 2004 to 2022, dozens of innovative clinical mass spectrometry enterprises have emerged in China. From the perspective of industrial chain, they are roughly divided into upstream instrument/reagent enterprises and midstream third-party medical testing centers.